Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 1426 AL 1440

Adult-onset phenylketonuria revealed by acute reversible dementia, prosopagnosia and parkinsonism

Rosini F, Rufa A, Monti L, Tirelli L, Federico A.

J Neurol. 2014 Dec;261(12):2446-8. doi: 10.1007/s00415-014-7492-7. Epub 2014 Oct 31.

Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease

Meyer PM, Tiepolt S, Barthel H, Hesse S, Sabri O.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):376-86. Epub 2014 Nov 11.

Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders

Bañuelos-Cabrera I, Valle-Dorado MG, Aldana BI, Orozco-Suárez SA, Rocha L.

Arch Med Res. 2014 Nov;45(8):677-86. doi: 10.1016/j.arcmed.2014.11.010. Epub 2014 Nov 20.

[Dementia and mild cognitive impairment in Parkinson's disease: a review]

Bocanegra Y, Trujillo-Orrego N, Pineda D.

Rev Neurol. 2014 Dec 16;59(12):555-69.

Topiramate improves psychiatric symptoms in a patient with Lewy body dementia

Ochoa JG.

Cogn Behav Neurol. 2014 Dec;27(4):222-3. doi: 10.1097/WNN.0000000000000039.

Donepezil-induced myoclonus in a patient with Alzheimer disease

Bougea A, Gerakoulis S, Anagnostou E, Paraskevas G, Kapaki E, Kararizou E.

Ann Pharmacother. 2014 Dec;48(12):1659-61. doi: 10.1177/1060028014550334. Epub 2014 Sep 8.

Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors

Ikeda K, Yanagihashi M, Sawada M, Hanashiro S, Kawabe K, Iwasaki Y.

Intern Med. 2014;53(9):1007-10. doi: 10.2169/internalmedicine.53.1857. Epub 2014 May 1.

Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation

Kamal MA, Priyamvada S, Anbazhagan AN, Jabir NR, Tabrez S, Greig NH.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):338-46. doi: 10.2174/18715273113126660137.

Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease

Song J, Park KA, Lee WT, Lee JE.

Int J Mol Sci. 2014 Jan 29;15(2):2119-29. doi: 10.3390/ijms15022119.

Lipid integration in neurodegeneration: an overview of Alzheimer's disease

Yadav RS, Tiwari NK.

Mol Neurobiol. 2014 Aug;50(1):168-76. doi: 10.1007/s12035-014-8661-5. Epub 2014 Mar 5.

Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target

Wilhelmus MM, de Jager M, Bakker EN, Drukarch B.

J Alzheimers Dis. 2014;42 Suppl 3:S289-303. doi: 10.3233/JAD-132492.

Epigenetic memory: the Lamarckian brain

Fischer A.

EMBO J. 2014 May 2;33(9):945-67. doi: 10.1002/embj.201387637. Epub 2014 Apr 9.

Human-induced pluripotent stem cells: potential for neurodegenerative diseases

Ross CA, Akimov SS.

Hum Mol Genet. 2014 Sep 15;23(R1):R17-26. doi: 10.1093/hmg/ddu204. Epub 2014 May 13.

Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease

Hroudová J, Singh N, Fišar Z.

Biomed Res Int. 2014;2014:175062. doi: 10.1155/2014/175062. Epub 2014 May 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias